News

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the most undervalued large cap stocks to buy according to analysts. On ...
Braun Stacey Associates cut its stake in Regeneron Pharmaceuticals by 4.5% during the first quarter, lowering its holdings to ...
When popular genetic testing company 23andMe filed for bankruptcy earlier this year and announced it was for sale, privacy ...
Genetic testing company 23andMe can proceed with a $305 million sale to the company’s co-founder Anne Wojcicki after a U.S.
Apogee TherapeuticsAPGE shares crumbled Monday, reversing a steep premarket gain, despite promising results for what could ...
The bispecific antibody market is experiencing rapid growth, primarily driven by the increasing prevalence of complex chronic diseases, such as cancer and autoimmune disorders, for which conventional ...
An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year ...